
### [MONDO:0004948](http://purl.obolibrary.org/obo/MONDO_0004948)
**Label:** chronic lymphocytic leukemia

**Subclasses:** [MONDO:0007190](http://purl.obolibrary.org/obo/MONDO_0007190) (leukemia, chronic lymphocytic, susceptibility to, 2), [MONDO:0019469](http://purl.obolibrary.org/obo/MONDO_0019469) (T-cell large granular lymphocyte leukemia), [MONDO:0007897](http://purl.obolibrary.org/obo/MONDO_0007897) (leukemia, chronic lymphocytic), [MONDO:0012936](http://purl.obolibrary.org/obo/MONDO_0012936) (leukemia, chronic lymphocytic, susceptibility to, 5), [MONDO:0012935](http://purl.obolibrary.org/obo/MONDO_0012935) (leukemia, chronic lymphocytic, susceptibility to, 4), [MONDO:0012318](http://purl.obolibrary.org/obo/MONDO_0012318) (leukemia, chronic lymphocytic, susceptibility to, 1), [MONDO:0012934](http://purl.obolibrary.org/obo/MONDO_0012934) (leukemia, chronic lymphocytic, susceptibility to, 3), 

**Corr. equiv. classes:** [OMIM:612558](http://purl.obolibrary.org/obo/OMIM_612558), [OMIM:612557](http://purl.obolibrary.org/obo/OMIM_612557), [OMIM:609630](http://purl.obolibrary.org/obo/OMIM_609630), [OMIM:612559](http://purl.obolibrary.org/obo/OMIM_612559), [Orphanet:86872](http://www.orpha.net/ORDO/Orphanet_86872), [OMIM:109543](http://purl.obolibrary.org/obo/OMIM_109543), [OMIM:151400](http://purl.obolibrary.org/obo/OMIM_151400), 

**Class expressions from DL-Learner:**

- [HP:0000006](http://purl.obolibrary.org/obo/HP_0000006) (Autosomal dominant inheritance) and [HP:0005550](http://purl.obolibrary.org/obo/HP_0005550) (Chronic lymphatic leukemia) 64.29%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0005550](http://purl.obolibrary.org/obo/HP_0005550) (Chronic lymphatic leukemia) 64.29%
- [HP:0005550](http://purl.obolibrary.org/obo/HP_0005550) (Chronic lymphatic leukemia) 55.11%
- [HP:0005558](http://purl.obolibrary.org/obo/HP_0005558) (Chronic leukemia) 34.70%
- [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) 21.91%
- [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) 19.76%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) 16.68%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) 16.57%
- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) 16.14%
- [HP:0002715](http://purl.obolibrary.org/obo/HP_0002715) (Abnormality of the immune system) 15.90%
- [HP:0000006](http://purl.obolibrary.org/obo/HP_0000006) (Autosomal dominant inheritance) 15.69%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) 15.22%
- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 15.01%
- Thing 15.00%
- [HP:0000001](http://purl.obolibrary.org/obo/HP_0000001) (All) 15.00%


